Potent regulation of microglia-derived oxidative stress and dopaminergic neuron survival: substance P vs. dynorphin

M L Block1, G Li, L Qin

  • 1Neuropharmacology Section, Laboratory of Pharmacology and Chemistry, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709, USA. Block@niehs.nih.gov

Insights

Substance P triggers microglial activation and dopamine neuron damage in Parkinson's disease models. Dynorphin counteracts this, suggesting neuropeptide balance is key for neuron survival.

Area of Science:

  • Neuroscience
  • Neuroimmunology
  • Cell Biology

Background:

  • Microglial activation is central to Parkinson's disease pathogenesis.
  • The substantia nigra contains peptides like substance P and dynorphin that may influence neuroinflammation.

Purpose of the Study:

  • To investigate the opposing roles of substance P and dynorphin in microglial activation and dopamine neuron toxicity.
  • To elucidate the mechanism by which substance P induces neurotoxicity.

Main Methods:

  • Primary mesencephalic neuron-glia cultures were utilized.
  • Microglial activation and reactive oxygen species (ROS) production were assessed.
  • NADPH oxidase (PHOX) knockout mice were used to determine the role of this enzyme.
  • Dopamine (DA) neuron function was measured via [3H] DA uptake.

Main Results:

  • Substance P (10^-13-10^-14 M) selectively induced microglia-dependent dopamine neuron toxicity.
  • Substance P activated microglial NADPH oxidase, leading to superoxide and ROS production.
  • Mice lacking functional NADPH oxidase were resistant to substance P-induced DA neuron dysfunction.
  • Dynorphin (10^-14 M) inhibited substance P (10^-13 M)-induced loss of [3H] DA uptake.

Conclusions:

  • A neuropeptide-mediated mechanism regulates microglia-derived oxidative stress in the substantia nigra.
  • The balance between dynorphin and substance P is critical for dopamine neuron survival in Parkinson's disease contexts.